All lobbying filings

AKIN GUMP STRAUSS HAUER & FELD

Lobbying for CHATTEM, INC. DBA OPELLA · Manufacturer of consumer healthcare products.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · New Jersey · House · Senate · $70,000.00 income · posted Jul 20, 2026

Official filing document

Bills named in this filing 2

HR 8646
Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027
HR 8495
Financial Services and General Government Appropriations Act, 2027

Lobbying activity 1

Health Issues

Issues related to implementation of the OTC Drug Monograph User Fee Program reauthorization and non-prescription drug status; Issues related to consumer health care products supply chain; Issues related to FY27 appropriations report language, including H.R. 8646 - Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027 and H.R. 8495 - Financial Services and General Government Appropriations Act, 2027.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.